DRUG-ELUTING STENTS VERSUS BARE METAL STENTS IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION UNDERGOING PRIMARY PERCUTANEOUS CORONARY INTERVENTION

Bilal Iqbal,Charles Ilsley,Tito Kabir,R. F. Smith,Rebecca Lane,Mark Mason,Abtehale Al-Hussaini,Andrew Archbold,Tom Crake,Sam Firoozi,Sundeep Kalra,Charles Knight,Pitt Lim,Anthony Mathur,Iqbal S. Malik,Pascal Meier,Roby Rakhit,Simon Redwood,Mark Whitbread,Dan Bromage,K Rathod,Andrew Wragg,Philip MacCarthy,Miles Dalby

DRUG-ELUTING STENTS VERSUS BARE METAL STENTS IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION UNDERGOING PRIMARY PERCUTANEOUS CORONARY INTERVENTION

2014

In primary percutaneous coronary intervention (PPCI) for ST-segment elevation myocardial infarction (STEMI), the relative safety of drug-eluting stents (DES) versus bare metal stents (BMS) continues to be debated. Whilst DES use is associated with reduced target lesion revascularization rates, stent

Keywords:

Elevation
Revascularization
Percutaneous coronary intervention
ST elevation
Myocardial infarction
Stent
Internal medicine
Cardiology
Medicine
in patient
Drug
bare metal
st elevation myocardial infarction
Diabetes mellitus

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations